NO975968L - Nye peptider for anvendelse i behandling av T-celle-mediert brusködeleggelse i autoimmune sykdommer - Google Patents

Nye peptider for anvendelse i behandling av T-celle-mediert brusködeleggelse i autoimmune sykdommer

Info

Publication number
NO975968L
NO975968L NO975968A NO975968A NO975968L NO 975968 L NO975968 L NO 975968L NO 975968 A NO975968 A NO 975968A NO 975968 A NO975968 A NO 975968A NO 975968 L NO975968 L NO 975968L
Authority
NO
Norway
Prior art keywords
autoimmune diseases
cell mediated
cartilage destruction
treatment
cells
Prior art date
Application number
NO975968A
Other languages
English (en)
Norwegian (no)
Other versions
NO975968D0 (no
Inventor
Gijsbertus Francisc Verheijden
Anna Maria Helena Boots
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO975968L publication Critical patent/NO975968L/no
Publication of NO975968D0 publication Critical patent/NO975968D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO975968A 1995-06-19 1997-12-18 Nye peptider for anvendelse i behandling av T-celle-mediert brusködeleggelse i autoimmune sykdommer NO975968D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95201656 1995-06-19
PCT/EP1996/002605 WO1997000270A1 (en) 1995-06-19 1996-06-17 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases

Publications (2)

Publication Number Publication Date
NO975968L true NO975968L (no) 1997-12-18
NO975968D0 NO975968D0 (no) 1997-12-18

Family

ID=8220392

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975968A NO975968D0 (no) 1995-06-19 1997-12-18 Nye peptider for anvendelse i behandling av T-celle-mediert brusködeleggelse i autoimmune sykdommer

Country Status (21)

Country Link
EP (1) EP0833842B1 (es)
JP (1) JPH11507919A (es)
KR (1) KR19990022972A (es)
CN (1) CN1155617C (es)
AT (1) ATE185151T1 (es)
AU (1) AU704942B2 (es)
BR (1) BR9608626A (es)
CA (1) CA2221981A1 (es)
DE (1) DE69604492T2 (es)
DK (1) DK0833842T3 (es)
ES (1) ES2139363T3 (es)
GR (1) GR3031990T3 (es)
HU (1) HU223275B1 (es)
IL (1) IL118524A (es)
MX (1) MX9710508A (es)
NO (1) NO975968D0 (es)
NZ (1) NZ311022A (es)
PL (1) PL185258B1 (es)
TR (1) TR199701658T1 (es)
WO (1) WO1997000270A1 (es)
ZA (1) ZA965163B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
PT1783222E (pt) 1998-10-23 2012-07-26 Kirin Amgen Inc Péptidos diméricos de trombopoietina que simulam a ligação ao receptor mpl e têm actividade trombopoiética
IL132611A0 (en) 1999-10-27 2001-03-19 Yeda Res & Dev Synthetic genes and polypeptides and pharmaceutical compositions comprising them
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
US7541184B2 (en) 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
EA011879B1 (ru) 2004-09-24 2009-06-30 Эмджин Инк. МОЛЕКУЛЫ С МОДИФИЦИРОВАННЫМ Fc ФРАГМЕНТОМ
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
CN112996801A (zh) * 2018-11-26 2021-06-18 北卡罗来纳州大学 用于捕获宿主细胞蛋白的肽配体

Also Published As

Publication number Publication date
NO975968D0 (no) 1997-12-18
MX9710508A (es) 1998-03-31
NZ311022A (en) 1999-11-29
ES2139363T3 (es) 2000-02-01
DE69604492D1 (de) 1999-11-04
GR3031990T3 (en) 2000-03-31
KR19990022972A (ko) 1999-03-25
PL324208A1 (en) 1998-05-11
CN1155617C (zh) 2004-06-30
HUP9802197A2 (hu) 1999-02-01
DK0833842T3 (da) 2000-04-03
AU704942B2 (en) 1999-05-06
PL185258B1 (pl) 2003-04-30
ATE185151T1 (de) 1999-10-15
DE69604492T2 (de) 2000-04-13
AU6224696A (en) 1997-01-15
JPH11507919A (ja) 1999-07-13
IL118524A (en) 2004-02-19
EP0833842A1 (en) 1998-04-08
CN1188483A (zh) 1998-07-22
CA2221981A1 (en) 1997-01-03
IL118524A0 (en) 1996-09-12
TR199701658T1 (xx) 1998-06-22
HUP9802197A3 (en) 1999-06-28
HU223275B1 (hu) 2004-04-28
BR9608626A (pt) 1999-06-15
EP0833842B1 (en) 1999-09-29
WO1997000270A1 (en) 1997-01-03
ZA965163B (en) 1997-01-23

Similar Documents

Publication Publication Date Title
ATE113475T1 (de) Hybride prokoagulierende proteine.
ATE337399T1 (de) Zusammensetzungen zur immuntherapie und diagnose von tuberculosis
TR199802082T2 (xx) Otoantigen ve otoim�n hastal�klar�n im�noterapisinde kullan�lmak i�in otoantigen yap�sal olarak ili�kili proteinler.
NO975968D0 (no) Nye peptider for anvendelse i behandling av T-celle-mediert brusködeleggelse i autoimmune sykdommer
MX9602495A (es) Peptidos novedosos derivados de autoantigeno para usarse en inmunoterapia de enfermedades autoinmunes.
NZ332427A (en) Peptides suitable for use in antigen specific immunosuppressive therapy
ATE183514T1 (de) Peptide des menschlichen proteins p53 zum gebrauch in menschlichen-zytotoxischen-t-zell- antwort-induzierenden kompositionen sowie menschliche p53-protein-spezifische t-lymphocyten
DE69329656D1 (de) Methoden zur detektion und behandlung von individuen mit abnormalen hla-a2/tyrosinase-peptidantigenen exprimierenden zellen
ES2151557T3 (es) Corpusculos de proteinas de estaño, estanniocalcina.
NO963487L (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
TR200100175T2 (tr) Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.
EA200001127A1 (ru) Бактериальные феромоны и их использование
EP0723454A4 (en) Novel tripeptides useful in immune and cns therapy
IT1283899B1 (it) Peptidi e loro usi nella terapia della malattia celiaca
ECSP993062A (es) Nuevos peptidos para ser usados en una terapia de tolerancia inducida para impedir las alteraciones autoinmunes, en particular, artritis reumatoidea
ATE260339T1 (de) Antikörper gegen menschliches restrictin
DE60115039D1 (de) Screeningverfahren für modulatoren von methyltransferase abhängiger chromosomenstabilität
ES2193601T3 (es) Utilizacion de peptidos de citrulina derivados a la filagrina en el marco del tratamiento de enfermedades autoinmunes.
Capppelli et al. “CHIVA” Care vs Stripping in the Treatment of Varicose Veins: Three-Years Follow-Up
Umansky et al. The Micro-Phlebo-Aspiration with the Phlebocurettes
MX9709192A (es) Proteina 4 quimiotactiva de monocitos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application